FDA Approves QULIPTA , the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine Biotech Investing
Lobe Sciences Announces Data Demonstrating That Its Combination Therapeutic Candidates are Significantly More Effective Than Monotherapy in mTBI and PTSD Cannabis Investing News
Merck to Hold Third-Quarter 2021 Sales and Earnings Conference Call on October 28 Pharmaceutical Investing
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age Video Interview
FDA grants Priority Review to ViiV Healthcare's New Drug Application for cabotegravir long-acting for prevention of HIV Pharmaceutical Investing
Gilead Marks Fifth Approval for Trodelvy® in Metastatic Triple-Negative Breast Cancer Under Project Orbis Initiative with Health Canada Authorization Biotech Investing
Americans are Frustrated by Unexpected Blurry Near Vision Issues, a New Survey Reveals Biotech Investing
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's Applications for Opdivo + Yervoy and Opdivo + Chemotherapy for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
Merck Announces KEYTRUDA® Met Primary Endpoint of Overall Survival in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib Pharmaceutical Investing
